Predictive value of serum interleukin-6 and interleukin-12 in children with chronic hepatitis B infection treated with interferon alpha.
Gora-Gebka
Magdalena
M
Liberek
Anna
A
Szydlowska-Lysiak
Wieslawa
W
Bako
Wanda
W
Korzon
Maria
M
D015415:Biomarkers / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019694:Hepatitis B, Chronic / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D018664:Interleukin-12 / Q000032:analysis / Q000097:blood*; D015850:Interleukin-6 / Q000032:analysis / Q000097:blood*; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D015415:Biomarkers; D016898:Interferon-alpha; D015850:Interleukin-6; D018664:Interleukin-12